Rigel Pharmaceuticals, Inc.

DB:RI2 Stock Report

Market Cap: €465.3m

Rigel Pharmaceuticals, Inc. Company Information

Rigel Pharmaceuticals, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Rigel Pharmaceuticals, Inc.
  • Ticker: RI2
  • Exchange: DB
  • Founded: 1996
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$491.107m
  • Listing Market Cap: US$465.324m
  • Shares Outstanding: 17.62m
  • Website: https://www.rigel.com

Number of Employees

Location

  • Rigel Pharmaceuticals, Inc.
  • 611 Gateway Blvd
  • Suite 900
  • South San Francisco
  • California
  • 94080
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RIGLNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDNov 2000
RI2DB (Deutsche Boerse AG)YesCommon StockDEEURNov 2000

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/28 11:00
End of Day Share Price 2024/11/28 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.